Oops! It appears that you have disabled your Javascript. In order for you to see this page as it is meant to appear, we ask that you please re-enable your Javascript!

Topic

Cancer

11

Jul

2017

A One-Bug Drug For the Immune System? Evelo Gets $50M to Test Concept

/

/

/

All, Cancer, Venture Capital

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

22

Jun

2017

Repare Secures $68M Series A to Discover ‘Synthetic Lethal’ Cancer Drugs

/

/

/

All, Cancer, Venture Capital

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

9

Jun

2017

ASCO Takeaways A-Z (Part 2)

/

/

/

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

8

Jun

2017

ASCO Takeaways From A-Z (Part 1)

/

/

/

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

5

Jun

2017

ASCO Notebook: Observations on Cancer R&D from Foundation Medicine, Halozyme, Blueprint, Nektar

/

/

/

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

6

Apr

2017

AACR Reflections: Genomics Adapts to I-O World, Scientists Stand Up, and Re-Thinking How to Fight Early-Stage Cancer

/

/

/

All, Cancer, Drugs

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

30

Mar

2017

Third Rock’s Tango Gets $55M for CRISPR-Enabled Synthetic Lethal Cancer Combos

/

/

/

All, Cancer, Drugs

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

8

Mar

2017

Dunsire Joins Xtuit to Fight Microenvironment; Spero Gets $51.7M for Antibiotics

/

/

/

All, Cancer, Drugs, Venture Capital

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

13

Feb

2017

Now More Than Ever: The Need for Personalized Medicine in Immuno-Oncology

/

Sarah Warren & Alessandra Cesano

/

/

All, Cancer, Diagnostics

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

5

Jan

2017

Neon Therapeutics Gets $70M to Push Neoantigen Cancer Vaccines

/

/

/

All, Cancer, Drugs, Venture Capital

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

27

Sep

2016

Google Translate Star Leaves Venter’s Human Longevity to Join Illumina’s Grail

/

/

/

All, Cancer, Diagnostics, People

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

27

Jun

2016

The VP is Asking for Advice on Cancer. Share Yours Before I Go To Washington

/

/

/

All, Cancer, Politics

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

19

May

2016

I-O: Who’s Doing What? (Part 2)

/

/

/

All, Cancer, Drugs

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

16

May

2016

Immuno-Oncology: Who’s Doing What?

/

/

/

All, Cancer, Drugs

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

10

Jan

2016

Illumina, Arch, Bezos, Gates Bet $100M on Deep Sequencing for Early Cancer Detection

/

/

/

All, Cancer, Diagnostics, Genomics

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

8

Jan

2016

All the Biotech Deals and Financings You Can Grok Before JP Morgan 2016

/

/

/

All, Cancer, People

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

21

Dec

2015

Which Biotechnologies Were Hyped, and Which Weren’t, in 2015

/

/

/

All, Cancer, Genomics, The Edge

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

10

Nov

2015

Pursuing a Hard Cancer Target: Q&A With Warp Drive CEO Laurence Reid

/

/

/

All, Cancer, Drugs

This content is available for subscribers of Timmerman Report. Subscribe Now Sign in to your account.

2

Oct

2015

Fallout from the Drug Pricing Fiasco, the New Thing in Genome Editing & More

/

/

/

This content is available for subscribers of the Timmerman Report. Subscribe Now

1

Oct

2015

The Next Macro (Phage) Thing in Immuno-Oncology

/

/

/

All, Cancer, Drugs

This content is available for subscribers of the Timmerman Report. Subscribe Now